Schellenberg Wittmer advised Trianon on the authorization process. Trianon obtained its FINMA license as asset manager of collective assets with the Swiss Financial Supervisory Authority (FINMA)....
Trianon SA’s FINMA License Authorization
Emerald Technology Ventures’ FINMA License
Schellenberg Wittmer advised Emerald Technology Ventures. Cleantech venture capital pioneer Emerald Technology Ventures obtained its FINMA license as asset manager of collective assets with the Swiss Financial...
Teylor AG’s Partnership With Taurus SA
Allen & Overy acted as Luxembourg counsel, while Schellenberg Wittmer Ltd. provided the Swiss law advice. Teylor AG, a Swiss fintech lending platform, has successfully executed...
Bioventure’s Series C Financing Round of Swiss Aphaia Companies
Schellenberg Wittmer advised Bioventure on series C financing round. Bioventure Club Deal Nine GmbH & Co KG on a Series C Financing Round of the Swiss...
Gilde Healthcare’s Investment in Swiss Dental Solutions
Schellenberg Wittmer advised Gilde Healthcare on the deal. Gilde Healthcare’s Private Equity Fund (Gilde Healthcare), a specialized healthcare investor, completed the acquisition of a majority of the...
Reichmuth Infrastructure’s 100MW Battery Storage Plant in Bavaria
Schellenberg Wittmer advised Swiss asset manager Reichmuth Infrastructure on the financing. Reichmuth Infrastructure has further expanded its renewables footprint in Germany with a joint venture to...
Chiesi Farmaceutici S.p.A.’s Acquisition of Raxone/idebenone From Santhera Pharmaceuticals AG
Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the operation. Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the sale of its Raxone®/idebenone business for all...
Sentinal Leasing’s CHF 20 Million Capital Increasing
Schellenberg Wittmer advised Sentinel Leasing on the deal. Sentinal Leasing completed its ordinary capital increase with a total issue amount of CHF 20 million as well...
BNP Paribas Suisse’s CHF 410 Million Placement Issued By EnBW International Finance
Schellenberg Wittmer has advised BNP Paribas Suisse. BNP Paribas Suisse completed the placement of CHF 410 million dual tranche senior fixed rate notes issued by EnBW International...
Swisscanto Private Equity’s Series B Financing Of Distran
Schellenberg Wittmer advised Swisscanto Private Equity. Swisscanto Private Equity completed the CHF 8.3 million Series B financing of the leading innovator in ultrasonic camera technology Distran....
Santhera Pharmaceuticals’ License Agreement With Catalyst Pharmaceuticals
Schellenberg Wittmer advises Santhera on license for North America for Vamorolone. Santhera Pharmaceuticals (SIX: SANN) has signed an exclusive license and collaboration agreement for vamorolone in...
OC Oerlikon’s CHF 340 Million Dual-Tranche Senior Unsecured Bonds
Schellenberg Wittmer advised OC Oerlikon on its placement of CHF 340 million dual-tranche senior unsecured bonds. OC Oerlikon, a global leader in surface engineering, polymer processing...